Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Cell Therapeutics
Pharma
BMS' Breyanzi bags FDA nod to treat follicular lymphoma
The FDA broadened the use of BMS' CAR-T therapy Breyanzi to another type of blood cancer, where it'll again compete with Gilead and Novartis drugs.
Angus Liu
May 16, 2024 10:56am
Bristol Myers bags FDA nod to bring CAR-T to CLL
Mar 15, 2024 9:46am
Legend CEO offers preview of high-stakes FDA adcomm for Carvykti
Mar 11, 2024 1:29pm
FDA approves first T-cell therapy for a solid tumor
Feb 17, 2024 12:15pm
FDA sets date for high-profile CAR-T advisory committee meeting
Feb 2, 2024 1:31pm
ASH: Abecma's overall survival data show why FDA called adcomm
Dec 11, 2023 7:30pm